Prabhakar D. Devanesan

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

Ercole L. Cavalieri, Douglas E. Stack, Prabhakar D. Devanesan et al. · Proceedings of the National Academy of Sciences · 1997 · 730 citations

Medicine, Molecular Biology, Oncology +17

Comparative dose—response tumorigenicity studies of dibenzo[<i>a,l</i>]pyrene versus 7, 12-dimethylbenz[<i>a</i>]anthracene, benzo[<i>a</i> and two dibenzo[<i>a,l</i>]pyrene dihydrodiols in mouse skin and rat mammary gland

Ercole L. Cavalieri, Sheila Higginbotham, N. V. S. Ramakrishna et al. · Carcinogenesis · 1991 · 246 citations

Pharmacy, Oncology, Toxicology +6

Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.

Matthews O. Bradley, Nigel L. Webb, Forrest H. Anthony et al. · PubMed · 2001 · 180 citations

Medicine, Oncology, Pharmacology +14

Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens

Indra Dwivedy, Prabhakar D. Devanesan, Paolo Cremonesi et al. · Chemical Research in Toxicology · 1992 · 134 citations

Life Sciences, Biochemistry, Toxicology +11

Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin

Eleanor G. Rogan, Prabhakar D. Devanesan, N. V. S. Ramakrishna et al. · Chemical Research in Toxicology · 1993 · 122 citations

Pharmacy, Toxicology, Analytical Toxicology +8